Jan P. Mattsson

Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis

Annalisa Frattini, Paul J. Orchard, Cristina Sobacchi et al. · Nature Genetics · 2000 · 676 citations

Life Sciences, Genetics, Molecular Genetics +6

Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

Richard J. Thompson, Henrik Arnell, Reha Artan et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 173 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial

Atsushi Nakajima, Mitsunori Seki, Shinya Taniguchi et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 169 citations

Medicine, Pharmacology, Pharmacotherapy +11

Omeprazole and bafilomycin, two proton pump inhibitors: Differentiation of their effects on gastric, kidney and bone H+-translocating ATPases

Jan P. Mattsson, Kalervo Väänänen, B. Wallmark et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1991 · 168 citations

Medicine, Pharmacology, Pharmacotherapy +12

Differential regulation of TRP channels in a rat model of neuropathic pain

Susanne Staaf, Sandra Oerther, Guilherme Lucas et al. · Pain · 2009 · 126 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17